Alicja Hubalewska-Dydejczyk

21PUBLICATIONS
50CO-AUTHORS
Medicinal and biomolecular chemistry not elsewhere classifiedTraditional Chinese medicine and treatmentsAutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 17, 2026
Bilateral adrenal lesions as a manifestation of prolonged glucocorticoid withdrawal in classical adrenal hyperplasia.

Anna Klasa, Agnieszka Stefańska, Anna Grochowska

|Mar 17, 2026
Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026.

Waldemar Misiorowski, Beata Kos-Kudła, Alicja Hubalewska-Dydejczyk

|Jan 28, 2026
The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response?

Maria Komisarz-Calik, Anna Bogusławska, Aleksandra Gamrat-Żmuda

|Sep 25, 2025
Lymphocytic colitis as a new disease possibly associated with autoimmune polyendocrine syndrome type 2 (APS-2).

Lidia Ziobro, Wiktoria Suchy, Ewa Płaczkiewicz-Jankowska

Pageof 4